132
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Type 1 Gaucher’s Disease. A Rare Genetic Lipid Metabolic Disorder Whose Diagnosis Was Concealed by Recurrent Malaria Infections in a 12-Year-Old Girl

ORCID Icon, , , , , & show all
Pages 1-7 | Received 28 Oct 2023, Accepted 18 Jan 2024, Published online: 19 Jan 2024

References

  • Pastores GM, Hughes DA. Gaucher disease. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, editors. Genereviews(®). Seattle: University of Washington, SeattleCopyright © 1993–2023, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved; 1993.
  • Sevitz H, Laher F, Varughese S, Nel M, McMaster A, Jacobson B. Baseline characteristics of 32 patients with Gaucher disease who were treated with imiglucerase: South African data from the International Collaborative Gaucher Group (ICGG) gaucher registry. South Afr Med J. 2022;112(1):21–26.
  • Stirnemann J, Belmatoug N, Camou F, et al. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci. 2017;18(2):441. doi:10.3390/ijms18020441
  • Stone WLBH, Master SR. Gaucher disease. 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448080/. Accessed January 18, 2024.
  • Disorders. NNOfR. Gaucher disease: national organization for rare disorders; 2018. Available from: https://rarediseases.org/rare-diseases/gaucher-disease/. Accessed January 18, 2024.
  • Murila F, Rajab J, Ireri J. Gaucher’s disease at a national referral hospital. East Afr Med J. 2008;85(9):455–458. doi:10.4314/eamj.v85i9.9662
  • Traoré M, Sylla M, Traoré J, Sidibé T, Oumar GC. Type 2 Gaucher\’s disease in a Malian family. Afr J Health Sci. 2004;11(1):67–69.
  • Essabar L, Meskini T, Lamalmi N, Ettair S, Erreimi N, Mouane N. Gaucher’s disease: report of 11 cases with review of literature. Pan Afr Med J. 2015;20(1):1.
  • Weinreb NJ, Camelo JS Jr, Charrow J, McClain MR, Mistry P, Belmatoug N. Gaucher disease type 1 patients from the ICGG Gaucher registry sustain initial clinical improvements during twenty years of imiglucerase treatment. Mol Gene Metabol. 2021;132(2):100–111. doi:10.1016/j.ymgme.2020.12.295
  • Dardis A, Michelakakis H, Rozenfeld P, et al. Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1. Orphanet J Rare Dis. 2022;17(1):1–17.
  • Chaabouni M, Aoulou H, Tebib N, et al. Gaucher’s disease in Tunisia (multicenter study)]. Rev Med Int. 2004;25(2):104–110. doi:10.1016/S0248-8663(03)00267-4
  • Chiabi A, Nguefack S, Kewe I, et al. Massive epistaxis due to profound malaria-induced thrombocytopenia in an adolescent: a case report at the yaounde gynaeco-obstetric and pediatric hospital, Cameroon. Health Sci Dis. 2014;15(3):1.
  • Leoni S, Buonfrate D, Angheben A, Gobbi F, Bisoffi Z. The hyper-reactive malarial splenomegaly: a systematic review of the literature. Malaria J. 2015;14(1):1–11. doi:10.1186/s12936-015-0694-3
  • Şahin GD, Teke HÜ, Karagülle M, et al. Gaucher cells or pseudo-gaucher cells: that’s the question. Turk J Haematol. 2014;31(4):428–429. doi:10.4274/tjh.2014.0019
  • Adas M, Adas G, Karatepe O, Altiok M, Ozcan D. Gaucher’s disease diagnosed by splenectomy. North Am J Med Sci. 2009;1(3):134–136.
  • Thomas AS, Mehta A, Hughes DA. Gaucher disease: haematological presentations and complications. Br J Haematol. 2014;165(4):427–440. doi:10.1111/bjh.12804